SPC361
Setmelanotide
Status:
VeittApplication date:
24.11.2021Application published:
15.12.2021Grant published:
15.2.2024
Max expiry date:
18.7.2036Medicine name:
ImcivreeMedicine for children:
No
Timeline
Today
24.11.2021Application
15.12.2021Publication
15.2.2024Registration
18.7.2036Expires
Marketing license
IS authorization number:
EU/1/21/1564/0001Date:
21.7.2021
Foreign authorization number:
EU/1/21/1564Date:
16.7.2021
Owner
Name:
Rhythm Pharmaceuticals, Inc.Address:
222 Berkeley Street, 12th floor, Boston US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP2970389